Show simple item record

dc.contributor.authorRezaei-Basiri, M
dc.contributor.authorRezazadeh, H
dc.contributor.authorAsvadi-Kermani, I
dc.contributor.authorDavoodi, A
dc.contributor.authorEghbal, MA
dc.contributor.authorGolchin, M
dc.contributor.authorSarmad, M
dc.date.accessioned2018-08-26T08:34:44Z
dc.date.available2018-08-26T08:34:44Z
dc.date.issued2014
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/52577
dc.description.abstractVitamin E is a natural antioxidant and its most common biologically active form is ?-tocopherol. The antiproliferative effects of ?-tocopherol have been previously demonstrated. In this study the antimutagenic effects of vitamin E on oncology and non oncology hospital nurses was investigated. A total of 138 female nurses from oncology and non oncology hospitals participated in the study. They received 200 mg/day vitamin E for 2 weeks. The urine samples before and after intake of vitamin E were collected and the nucleus of urothelial cells were evaluated with comet assay. The length of epithelial cells nuclei correlated with increased fracture rate of DNA. Nucleolus length of urine epithelial cells of all nursing staff before and after vitamin E treatment were measured and the data were evaluated by student t-test and SPSS. Our study showed that 20% of nursing staff have apoptosis and DNA fracture in the nucleolus of their urine epithelial cells and DNA damage in the urothelial cells of exposed nurses was significantly higher than the control group (P<0.05). The antimutagenic activity of vitamin E had significant effects on oncology hospital nurses effectively in repairing DNA damage and decreasing their nucleus length in urine epithelial cells. We propose that the higher therapeutic doses of vitamin E and increasing the length of treatment period will be effective against DNA strand breakage and may have more effect on oncology nurses. é Georg Thieme Verlag KG Stuttgart.
dc.language.isoEnglish
dc.relation.ispartofDrug Research
dc.subjectalpha tocopherol
dc.subjectDNA
dc.subjectalpha tocopherol
dc.subjectantimutagenic agent
dc.subjectDNA
dc.subjectadult
dc.subjectage
dc.subjectantimutagenic effect
dc.subjectapoptosis
dc.subjectarticle
dc.subjectcancer center
dc.subjectcomet assay
dc.subjectcontrolled study
dc.subjectDNA damage
dc.subjectDNA strand breakage
dc.subjectdrug effect
dc.subjectepithelium cell
dc.subjectfemale
dc.subjecthuman
dc.subjectnucleolus
dc.subjectnursing staff
dc.subjectoccupational exposure
dc.subjectoncology
dc.subjectoncology nursing
dc.subjecturinalysis
dc.subjectvitamin supplementation
dc.subjectcell nucleus
dc.subjectcomet assay
dc.subjectdrug effects
dc.subjectgenetics
dc.subjectmetabolism
dc.subjectnurse
dc.subjectoncology nursing
dc.subjectprocedures
dc.subjectAdult
dc.subjectAntimutagenic Agents
dc.subjectApoptosis
dc.subjectCell Nucleus
dc.subjectComet Assay
dc.subjectDNA
dc.subjectDNA Damage
dc.subjectEpithelial Cells
dc.subjectFemale
dc.subjectHumans
dc.subjectNurses
dc.subjectOncology Nursing
dc.subjectVitamin E
dc.titleAntimutagenic effects of vitamin e on oncology and non oncology hospital nurses by comet assay
dc.typeArticle
dc.citation.volume64
dc.citation.issue7
dc.citation.spage337
dc.citation.epage342
dc.citation.indexScopus
dc.identifier.DOIhttps://doi.org/10.1055/s-0033-1361163


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record